Świderska, J.; Kozłowski, M.; Gaur, M.; Pius-Sadowska, E.; Kwiatkowski, S.; Machaliński, B.; Cymbaluk-Płoska, A.
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer. Diagnostics 2022, 12, 251.
https://doi.org/10.3390/diagnostics12020251
AMA Style
Świderska J, Kozłowski M, Gaur M, Pius-Sadowska E, Kwiatkowski S, Machaliński B, Cymbaluk-Płoska A.
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer. Diagnostics. 2022; 12(2):251.
https://doi.org/10.3390/diagnostics12020251
Chicago/Turabian Style
Świderska, Janina, Mateusz Kozłowski, Maria Gaur, Ewa Pius-Sadowska, Sebastian Kwiatkowski, Bogusław Machaliński, and Aneta Cymbaluk-Płoska.
2022. "Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer" Diagnostics 12, no. 2: 251.
https://doi.org/10.3390/diagnostics12020251
APA Style
Świderska, J., Kozłowski, M., Gaur, M., Pius-Sadowska, E., Kwiatkowski, S., Machaliński, B., & Cymbaluk-Płoska, A.
(2022). Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer. Diagnostics, 12(2), 251.
https://doi.org/10.3390/diagnostics12020251